INTEGRATED BIOPHARMA INC
INBP · Pharmaceutical Preparations
Latest available SEC filing: 10-K ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-K
SEC filing · Filed
-
Friedman Eric J: Form 4/A
Insider disclosure · Filed · Report period 24 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- INBP · 45811V105 - COM
Company details and SEC sources
CIK 0001016504 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- INBP on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 225 Long Avenue, Building 15, Hillside, NJ, 07205
- Incorporated in
- DE
- Fiscal year end
- 30 June
- Former names on EDGAR
- INTEGRATED HEALTH TECHNOLOGIES INC (to 16 Apr 2003), CHEM INTERNATIONAL INC (to 14 May 2002)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields